Unresolved issues in biologic therapy for rheumatoid arthritis | Nature Reviews Rheumatology
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
U.S. International Trade Commission will investigate AbbVie claims that rival stole secrets - STAT
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
Topical nanocarriers for management of Rheumatoid Arthritis: A review - ScienceDirect
About TRUXIMA® (rituximab-abbs) | Rheumatoid Arthritis | See Safety Info
Biological Treatments for Rheumatoid Arthritis
Frontiers | Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies
Do generics producers have what it takes to tackle complex and specialty drugs?
Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When? - European Medical Journal
Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects: Molecular Therapy - Methods & Clinical Development
Nocebos in rheumatology: emerging concepts and their implications for clinical practice | Nature Reviews Rheumatology
Biologics in rheumatoid arhritis (RA) | NRAS
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update | Annals of the Rheumatic Diseases
Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis | Neurology Neuroimmunology & Neuroinflammation
Safety of biologic therapy in rheumatoid arthritis | Nature Reviews Rheumatology
IJMS | Free Full-Text | Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Sulfasalazine Shortage: What to Do If You Can't Access Azulfidine
About TRUXIMA® (rituximab-abbs) | Rheumatoid Arthritis | See Safety Info
Chemokine receptor CCR1: new target for asthma therapy: Trends in Pharmacological Sciences
Biosimilar Prices: How Much They Cost and How to Save - GoodRx
Top developments in biosimilars during 2019 - GaBI Journal
